Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.302SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.55SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.51SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.308SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.138SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.379SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.240SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.240.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.243SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
R.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.216SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.471SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.420SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
L.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.518SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.551SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.207SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.604SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.111SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.619SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.23.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.316SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.436SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.558SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.518SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.368SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.404SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.306SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.328SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.533SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.528SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.91 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.617SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.383SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.40SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.95 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.189SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used